Loading stock data…
NUS
$7.19-0.11 (-1.51%)
Market ClosedLast close May 1
Nu Skin Enterprises, Inc., together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Nu Skin Enterprises, Inc. in the Consumer Defensive sector is trading at $7.19. The stock is currently near its 52-week low of $5.63, remaining 25.7% below its 200-day moving average. Technical signals show neutral RSI of 41 and bearish MACD signal, explaining why NUS maintains its current current market pressure. The Whystock Score of 50/100 suggests a balanced risk-reward profile.
Ecosystem Influences
Neutral momentum (RSI 41) — price action in range
Long-term trend bearish (Price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Loading Financials...
Peer Comparison
Whystock Valuation Model
Whystock fair value is estimated using a trailing P/E model adjusted for return on equity: Fair P/E = 18 + (ROE × 20). Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. A base P/E of 18 represents a typical market multiple, scaled upward for companies that earn high returns on equity. The result is a theoretical "normalised" price — not a price target or investment advice. Large deviations are common for high-growth or loss-making companies.
Current Price$7.19
Potential Upside
772.9%
Whystock Fair Value$62.76
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Fundamentals
Nu Skin Enterprises, Inc., together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiS...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$367.35M
P/E Ratio
Value territory. Trading at a high yield relative to earnings.
2.35
Beta
High-beta play. Expect amplified moves vs. the broad market.
1.07
Div Yield
Strong income play. Yield provides a meaningful total return floor.
321.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
12.52%
Volume
Today's trading volume
418,126
Recent News
Estimating The Fair Value Of Nu Skin Enterprises, Inc. (NYSE:NUS)
Key Insights The projected fair value for Nu Skin Enterprises is US$10.00 based on 2 Stage Free Cash Flow to Equity...
Nu Skin Enterprises Q4 Earnings Lag Estimates, Revenues Down Y/Y
NUS' fourth-quarter earnings and sales miss estimates, with revenues down 16.9% Y/Y and broad declines across key global regions.
Nu Skin Enterprises, Inc. Q4 2025 Earnings Call Summary
Moby summary of Nu Skin Enterprises, Inc.'s Q4 2025 earnings call
Nu Skin Enterprises Q4 Earnings Call Highlights
Nu Skin Enterprises (NYSE:NUS) said it delivered fourth-quarter and full-year 2025 results within its guidance range, while leadership emphasized that 2026 will be a “pivotal year” focused on launching its Prysm iO intelligent wellness platform, expanding into India, and continuing operational effic
Nu Skin Enterprises Inc (NUS) Q4 2025 Earnings Call Highlights: Strong Earnings Growth and ...
Nu Skin Enterprises Inc (NUS) reports a 51% growth in earnings per share and unveils plans for global expansion, despite facing currency headwinds and higher tax rates.